75 results
Page 4 of 4
6-K
EX-99.1
fhkso00b44o94x3rr
21 Jan 20
Zai Lab Announces Proposed Public Offering of American Depositary Shares
5:28pm
6-K
EX-99.1
fzhidi
27 Dec 19
Zai Lab Announces NMPA Approval of ZEJULA® (Niraparib) in China as Maintenance Therapy for Patients with Recurrent Ovarian Cancer
7:51am
20-F/A
EX-10.15
b9bltguvro sm9
23 Aug 19
Annual report (foreign) (amended)
5:00pm
20-F/A
EX-10.15
bhxg kyh3
26 Jun 19
Annual report (foreign) (amended)
6:07am
424B2
kkphgszgwuqvu6y
6 May 19
Prospectus for primary offering
6:04am
6-K
EX-99.1
y5a40
3 May 19
Zai Lab Announces Pricing of Public Offering of American Depositary Shares
12:00am
6-K
EX-1.1
qqra7 2zj30h98eesv
2 May 19
Current report (foreign)
11:39am
424B5
3911p4k
1 May 19
Prospectus supplement for primary offering
5:26pm
6-K
EX-99.1
1wv0x
1 May 19
Current report (foreign)
4:06pm
6-K
EX-99.1
3kar5d xh7w7
22 Oct 18
Zai Lab Announces Approval of ZEJULA® (Niraparib) for Patients with Relapsed Ovarian Cancer in Hong Kong
7:48am
20-F
aoqh1lgy9z9
30 Apr 18
Annual report (foreign)
9:07am
20-F
EX-4.11
82p oqbv4y2ajx
30 Apr 18
Annual report (foreign)
9:07am